NASDAQ : WGS
GeneDx Holdings Corp. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 71.02 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.12B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.91B |
| Enterprise Value | 1.95B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 29.82M |
| Shares Outstanding | 29.82M |
| Shares Change (YoY) | +2.38% |
| Shares Change (QoQ) | +1.28% |
| Owned by Insiders (%) | 1.86% |
| Owned by Institutions (%) | 82.37% |
| Float | 20.44M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 96.68 |
| PS Ratio | 4.21 |
| Forward PS | 3.55 |
| PB Ratio | 7.82 |
| P/TBV Ratio | 18.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 4.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.30 |
| Quick Ratio | 2.90 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.00 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -40.80% |
| Return on Assets (ROA) | -7.89% |
| Return on Invested Capital (ROIC) | -22.49% |
| Return on Capital Employed (ROCE) | -14.67% |
| Weighted Average Cost of Capital (WACC) | 13.98% |
| Revenue Per Employee | $349,558 |
| Profits Per Employee | -$81,813 |
| Employee Count | 1,300 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 9.35 |
Taxes
| Measure | Value |
|---|
| Income Tax | 62,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.97 |
| 52-Week Price Change | -53.19% |
| 50-Day Moving Average | 78.58 |
| 200-Day Moving Average | 71.70 |
| Relative Strength Index (RSI) | 43.54 |
| Average Volume (20 Days) | 822,400 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 6.02M |
| Short Previous Month | 5.63M |
| Short % of Shares Out | 20.19% |
| Short % of Float | 29.45% |
| Short Ratio (days to cover) | 7.23 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 454.43M |
| Gross Profit | 315.30M |
| Operating Income | -59.67M |
| Pretax Income | -106.30M |
| Net Income | -106.36M |
| EBITDA | -33.70M |
| EBIT | -59.67M |
| Loss Per Share | -$3.64 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 132.55M |
| Total Debt | 167.40M |
| Net Cash | -34.85M |
| Net Cash Per Share | -$1.17 |
| Equity (Book Value) | 244.22M |
| Book Value Per Share | 8.19 |
| Working Capital | 171.73M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -48.71M |
| Capital Expenditures | -27.09M |
| Depreciation & Amortization | 25.98M |
| Net Borrowing | 35.37M |
| Free Cash Flow | -75.80M |
| FCF Per Share | -$2.54 |
Margins
| Measure | Value |
|---|
| Gross Margin | 69.38% |
| Operating Margin | -13.13% |
| Pretax Margin | -23.39% |
| Profit Margin | -23.40% |
| EBITDA Margin | -7.41% |
| EBIT Margin | -13.13% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.38% |
| Shareholder Yield | -2.38% |
| Earnings Yield | -5.68% |
| FCF Yield | -3.97% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $93.50 |
| Price Target Difference | 45.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 19.39% |
| EPS Growth Forecast (3Y) | 8.33% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 4, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:33 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.98 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |